Artivion amends agreements with Endospan (NYSE:AORT)
2024-07-01
Artivion (NYSE:AORT) on Monday said it has amended its credit facility and option purchase agreements with Endospan. Through the agreement, Artivion will provide Endospan with $25M of additional debt funding to obtain FDA approval for NEXUS. The amendment to the agreement also includes an upfront payment associated with the purchaseContinue Reading